Transamerica Financial Advisors’s Avanos Medical AVNS Stock Holding History

Transamerica Financial Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$98	Hold	7	–	–	﹤0.01%	1750
2025 Q4	$79	Sell	7 -81	-92%	-$927	﹤0.01%	1708
2025 Q3	$1.02K	Buy	+88	New	+$1.03K	﹤0.01%	1166
2016 Q2	–	Sell	-73	Closed	-$3K	–	413
2016 Q1	$3K	Sell	73 -50	-41%	-$1.33K	﹤0.01%	640
2015 Q4	$5K	Hold	123	–	–	﹤0.01%	666
2015 Q3	$4K	Sell	123 -104	-46%	-$3.63K	﹤0.01%	663
2015 Q2	$10K	Sell	227 -264	-54%	-$11.8K	﹤0.01%	628
2015 Q1	$25K	Sell	491 -444	-47%	-$20.6K	﹤0.01%	508
2014 Q4	$43K	Buy	+935	New	+$36.7K	﹤0.01%	371

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Transamerica Financial Advisors's AVNS Position: Q1 2026 in Review

Transamerica Financial Advisors held its Avanos Medical (AVNS) position steady in Q1 2026 at 7 shares worth $98. The position accounts for ﹤0.01% of the portfolio, ranked #1750.

Transamerica Financial Advisors first reported a position in AVNS in Q4 2014 and has held it in 9 quarters since. The position peaked at $43K in Q4 2014. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

Transamerica Financial Advisors held 7 shares of Avanos Medical worth $98 as of Q1 2026.
Transamerica Financial Advisors left its Avanos Medical share count unchanged in Q1 2026.
Avanos Medical made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q1 2026, its #1750 holding.
Transamerica Financial Advisors first reported a position in Avanos Medical in Q4 2014 and has held it in 9 quarters since.
Transamerica Financial Advisors's Avanos Medical position peaked at $43K in Q4 2014.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Transamerica Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.